Introduction: Cervical cancer is a major cause of deaths in female in low- and middle-income countries. The disease is preventable by introducing screening tests such as Pap smears, visual inspection with acetic acid (VIA) and HPV DNA testing. Recently, the first vaccine against human papillomavirus (HPV) was introduced to the health care market t

https://www.youtube.com/watch?v=QnmnyZ14A4wIn health systems, although there are many stakeholders with different interests (healthcare practitioners, policymakers, industry, patients and the public), many share the value of better health for all. However, when a decision needs to be made, it is not

Coming to Thailand with utmost excitement in receiving first-hand mentorship from senior HTA researchers from Health Intervention and Technology Assessment Program (HITAP) was truly fulfilling. We were not only taught on enhancing our skills in performing economic evaluation and budget impact analys

On 9th May 2018 during the 7th HTAsiaLink conference in Chiang Mai, Thailand, editors of 5 translations of the book ‘Testing Treatments: better research for better healthcare’ gave a short talk in the promotional session for the book in each language. Testing Treatment: better r

According to World Health Organization (WHO) health system framework an efficient health system results in equitable access to essential health technologies with assured quality, safety, efficacy, and cost-effectiveness. National policies, essential health technology list, and evidenced-based selection of health technologies using health technology

The recent Indonesia visit is an illustration of iDSI’s ongoing commitment to building capacity in developing countries. HITAP visits help national bodies learn how to conduct Health Technology Assessments, strengthening decision-making processes and enabling gains in the quantity and quality of hea

Abstract BACKGROUND: At present, health technology assessment (HTA) guidelines of many countries including Thailand have recommended EQ-5D as the preferred method for assessing utility. This study aims to generate an EQ-5D-5L value set based on societal preferences of Thai population. METHODS

คู่มือการประเมินเทคโนโลยีด้านสุขภาพสำหรับประเทศไทย ฉบับที่ 1 (พ.ศ. 2551) ได้รับการพัฒนาขึ้นเพื่อเป็นแนวทางมาตรฐานในการวิเคราะห

The Current Capacity and Future Development of Economic Evaluation for Policy Decision-Making: A Survey among Researchers and Decision-Makers in Thailand. Usa Chaikledkaew1,2 Chanida Lertpitakpong2 Yot Teerawattananon2 Montarat Thavorncharoensap1,2 Viroj Tangcharoensathien 3 1Department of Phar

The decision-making challenge for reimbursing costly innovative drugs Health technology assessment (HTA) is a multi-disciplinary approach crucial to the decision-making framework for drug reimbursements. It gives evidence of the drug’s cost-effectiveness and affordability to help policymakers decide